Patients identified as high-risk, characterized by markers such as FCER1G and TYROBP, display “cold tumor” phenotypes, typified by low infiltration of CD8 T cells and elevated levels of PD-L1-expressing macrophages. Here, TYROBP is linked to neoplasm.